About this trial
Nowadays, no studies compare the T-stenting And Minimal Protrusion (TAP) and External Minicrush techniques in treating complex coronary bifurcation, so eventually, procedural, clinical and safety differences remain unknown.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients >18 years of age
Patients with an indication for PCI, including chronic coronary syndrome and acute coronary syndromes (STEMI, NSTEMI, unstable angina)
Patients with at least one true coronary bifurcation according to the Medina classification 1.1.1, 0.1.1, 1.0.1, 0.0.1
Disqualifiers
Patients who do not want or cannot sign the informed consent for the procedure.
Patients with severe peripheral vascular disease that limits vascular access to the point of making the procedure unsafe.
Patients with a life expectancy of <1 year.
Patients with planned major surgery require prolonged discontinuation of antiplatelet therapy.
Trial population
ACS or CCS patients with complex coronary bifurcation lesions with the indication of PCI.
Trial design
Case-control
Prospective
Treatments tested in this trial
Percutaneous Coronary Intervention
Procedure/SurgeryPercutaneous coronary intervention is a procedure that require coronary stenosis dilatation with dilatation catheter balloon and generally stent implantation. The study involve coronary stenosis at bifurcation level that require complex coronary techniques such as External Minicrush or TAP technique.
Treatment groups
Trial outcomes
Primary outcomes
Target Lesion Failure (TLF)
a composite of cardiac death and target vessel-related myocardial infarction (TV-MI), including Q wave, non-Q wave myocardial infarction (MI), and ischemia-driven target lesion revascularization (TLR)
Secondary outcomes
Stent thrombosis (ST)
Thrombosis of the stent after PCI
Intrastent-restenosis (ISR)
Intrastent restenosis with \>50% of the stent diameter
Target Vessel MI (TVMI)
Target vessel myocardial infarction at follow-up
Sponsors and contacts
Click on the lead sponsor to view all of their trials.